Cargando…
Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients
BACKGROUND: Fluoroquinolones (FQs) are potential drugs that inhibit DNA synthesis and are used in the treatment of multidrug-resistant tuberculosis (TB) and short-term anti-TB regimens. In recent years, a high proportion of FQ resistance has been observed in Mycobacterium tuberculosis isolates. The...
Autores principales: | Kabir, Saba, Tahir, Zarfishan, Mukhtar, Nadia, Sohail, Muhammad, Saqalein, Muhammad, Rehman, Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216623/ https://www.ncbi.nlm.nih.gov/pubmed/32393213 http://dx.doi.org/10.1186/s12890-020-1172-4 |
Ejemplares similares
-
New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
por: Malik, Seidu, et al.
Publicado: (2012) -
gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027
por: Drudy, Denise, et al.
Publicado: (2007) -
Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis
por: Li, Jing, et al.
Publicado: (2014) -
1495 Resistance of Fluoroquinolone in Orientia tsutsugamushi Due to gyrA Mutation in Scrub typhus
por: CHO, Soo Kyung, et al.
Publicado: (2014) -
Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella
enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)